Hyperfine (HYPR) Liabilities and Shareholders Equity (2020 - 2026)
Hyperfine posted quarterly Liabilities and Shareholders Equity of $60.3 million for Q1 2026, up 13.04% year-on-year from $53.4 million in Q1 2025, and up 9.19% on a QoQ basis from $55.3 million in Q4 2025.
Hyperfine (HYPR) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $60.3 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 13.04% year-over-year to $60.3 million; the trailing twelve-month figure through Mar 2026 stood at $202.3 million (down 21.65% YoY), and the FY2025 full-year result was $55.3 million, down 6.18% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $60.3 million, up from $55.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $178.8 million in Q1 2022 and bottomed at $41.5 million in Q3 2025.
- The 5-year median for Liabilities and Shareholders Equity is $85.4 million (2024), against an average of $94.2 million.
- The widest annual swing landed in 2025, when Liabilities and Shareholders Equity tumbled 40.96%; it then increased 13.04% in 2026.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $134.1 million in 2022, then decreased by 29.73% to $94.2 million in 2023, then plunged by 37.47% to $58.9 million in 2024, then slipped by 6.18% to $55.3 million in 2025, then grew by 9.19% to $60.3 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $60.3 million (Q1 2026), $55.3 million (Q4 2025), and $41.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 60.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.34 Mn |
| Dec 31, 2025 | 55.26 Mn |
| Sep 30, 2025 | 41.51 Mn |
| Jun 30, 2025 | 45.23 Mn |
| Mar 31, 2025 | 53.38 Mn |
| Dec 31, 2024 | 58.90 Mn |
| Sep 30, 2024 | 69.39 Mn |
| Jun 30, 2024 | 76.61 Mn |
| Mar 31, 2024 | 85.44 Mn |
| Dec 31, 2023 | 94.20 Mn |
| Sep 30, 2023 | 103.06 Mn |
| Jun 30, 2023 | 112.61 Mn |
| Mar 31, 2023 | 122.10 Mn |
| Dec 31, 2022 | 134.05 Mn |
| Sep 30, 2022 | 148.33 Mn |
| Jun 30, 2022 | 161.71 Mn |
| Mar 31, 2022 | 178.83 Mn |
| Dec 31, 2021 | 202.47 Mn |
| Sep 30, 2021 | 207.94 Mn |
| Jun 30, 2021 | 208.25 Mn |
| Mar 31, 2021 | 208.45 Mn |
| Dec 31, 2020 | 71.53 Mn |